Clinical trials - Press Releases

Date	Title	Company
25-Mar-2022	Envirotainer’s Releye® RAP container already approved by 10 airlines	Envirotainer
23-Mar-2022	4D pharma announces positive interim results from the Phase I/II study of the combination of MRx0518 and KEYTRUDA(R) (pembrolizumab) for the treatment of renal cell carcinoma	4D pharma
22-Mar-2022	Innovative collaboration to offer heart rhythm checks throughout the North West to detect Atrial Fibrillation via Community Pharmacies	Daiichi Sankyo and O’Brien’s Pharmacies Group
22-Mar-2022	Zygel’s anticipated impact on underserved fragile X syndrome market sees sales estimates of $18.1 million, says GlobalData	Zynerba Pharmaceuticals
22-Mar-2022	Sajid Javid is sticking his head in the sand, expert warns, as long Covid cases mount and immunity falls	London Medical Laboratory
22-Mar-2022	CELL AND GENE THERAPY CATAPULT LAUNCHES 2021 CLINICAL TRIALS DATABASE REPORT	The Cell and Gene Therapy Catapult (CGT Catapult)
22-Mar-2022	Biocomposites signs agreement with Zimmer Biomet to distribute new genex Bone Graft Substitute	Biocomposites
22-Mar-2022	CD Bioparticles Introduces the Launch of Organic Gold Nanoparticles	CD Bioparticles
16-Mar-2022	Clinical trial team at Royal Berkshire NHS Foundation Trust innovates with SMART on FHIR data automation platform, Archer	IgniteData
15-Mar-2022	AlzeCure presents new clinical data with ACD856 at Alzheimer's conference	AlzeCure Pharma AB
11-Mar-2022	Why Are Energy-Based Aesthetic Devices Becoming Popular in MEA	P&S Intelligence
10-Mar-2022	Freeline Announces First Patient Dosed in the Phase 1/2 B-LIEVE Dose-Confirmation Trial in Hemophilia B	Freeline Therapeutics Holdings plc
10-Mar-2022	Transgene to Present New Positive Preliminary Phase I Data on TG4050 (myvac® platform), its Individualized Therapeutic Cancer Vaccine, at AACR 2022	Transgene
09-Mar-2022	HUTCHMED Receives a US$15 million Milestone from AstraZeneca for Initiating Start-up Activities for a Global Phase III Study of ORPATHYS® in Lung Cancer	HUTCHMED
08-Mar-2022	Rapid Microbial Methods, Contamination Control, Sterility Assurance and Environmental Monitoring to be covered at Microbiology East Coast Conference in Boston	SMi Group
07-Mar-2022	UK Regulator Cites CluePoints’ Solutions in Updated Guidance	CluePoints
05-Mar-2022	Exclusive Chemaxon Interview released - Sponsor at AI in Drug Discovery Conference 2022	SMi Group
03-Mar-2022	Nirsevimab significantly protected infants against RSV disease in Phase 3 trial	Sanofi
03-Mar-2022	Nirsevimab significantly protected infants against RSV disease in Phase 3 trial	Sanofi
02-Mar-2022	Analyses from NAVIGATOR and PATHWAY trials presented at the 2022 AAAAI Annual Meeting	AstraZeneca